2017 AHA / ACC Update on 2014 Valvular Disease Q3

According to the
“2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure” p 258

“Anticoagulation is indicated in patients with AF _________________ with native aortic valve disease, tricuspid valve disease, or MR”

Class of Recommendation = I

a) regardless of CHA2DS2-VASc score
b) and a CHA2DS2-VASc score of 1 or greater
c) and a CHA2DS2-VASc score of 2 or greater
d) and a CHA2DS2-VASc score of 3 or greater

click here for answer

(C)

“Anticoagulation is indicated in patients with AF and a CHA2DS2-VASc score of 2 or greater with native aortic valve disease, tricuspid valve disease, or MR (36–38).”

Leave Comment

Your email address will not be published. Required fields are marked *